TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
QuiaPEG Pharmaceuticals AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
|
157 |
Financial expenses |
17
|
37
|
141 |
Earnings before taxes |
-8,740
|
-9,062
|
-10,836 |
EBITDA |
-6,132
|
-6,775
|
-9,103 |
Total assets |
14,062
|
14,379
|
13,588 |
Current assets |
498
|
1,228
|
883 |
Current liabilities |
3,211
|
10,501
|
12,440 |
Equity capital |
10,851
|
3,841
|
879 |
- share capital |
103
![]() |
103
|
112 |
Employees (average) |
3
|
4
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.2%
|
26.7%
|
6.5% |
Turnover per employee |
0
![]() |
0
|
31 |
Profit as a percentage of turnover | -6901.9% | ||
Return on assets (ROA) |
-62.0%
|
-62.8%
|
-78.7% |
Current ratio |
15.5%
|
11.7%
|
7.1% |
Return on equity (ROE) |
-80.5%
|
-235.9%
|
-1232.8% |
Change turnover |
0
|
-144
|
-1,196 |
Change turnover % |
-100%
|
-88% | |
Chg. No. of employees |
-1
![]() |
-1
|
2 |
Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.